Ashkon Software

   







 


CYBX - Cyberonics, Inc.

Cyberonics, Inc. logo Cyberonics, Inc. (CYBX) is a medical technology company that specializes in developing and manufacturing neuromodulation devices. The company's products are used in the treatment of epilepsy and other neurological disorders.

Cyberonics' primary product is the Vagus Nerve Stimulation Therapy (VNS Therapy) System, which is used to treat patients with epilepsy that are not well-controlled by medication. The VNS Therapy System involves the implantation of a small device under the skin, which delivers electrical signals to the vagus nerve in the neck.

Cyberonics was founded in 1987 and is headquartered in Houston, Texas. As of my knowledge cutoff of September 2021, the company was performing well financially, with strong revenue and earnings growth in recent years. The company's revenue for the fiscal year 2020 was $344 million, representing an increase of 6.2% compared to the previous year. Net income for the same period was $65.6 million, an improvement from $49.3 million in the previous year.

Cyberonics has a market capitalization of approximately $1.4 billion as of September 2021, and its stock is listed on the NASDAQ stock exchange under the ticker symbol CYBX.

The medical technology industry is subject to various risks, including regulatory risks, competitive risks, and changes in healthcare policies. However, Cyberonics' focus on developing innovative neuromodulation devices and its strong financial performance should position it well for continued success in

 



 

 

 
Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer